5464-92-6 Usage
Uses
Used in Pharmaceutical Research and Development:
1-Phenyl-1,2,3,4-tetrahydroisoquinoline is used as a key compound in pharmaceutical research and development for its potential as a psychoactive agent. Its unique structure and properties allow researchers to investigate its effects on the central nervous system and its potential use in treating neurological disorders.
Used in Understanding Structure-Activity Relationships:
1-Phenyl-1,2,3,4-tetrahydroisoquinoline is utilized in the study of structure-activity relationships of isoquinoline derivatives. By examining the compound's interactions with biological targets, researchers can gain insights into the design and development of new drugs with improved efficacy and selectivity.
Used in the Treatment of Neurological Disorders:
1-Phenyl-1,2,3,4-tetrahydroisoquinoline is explored for its potential therapeutic applications in the treatment of various neurological disorders. Its unique chemical properties and interactions with the central nervous system make it a promising candidate for the development of new treatments for conditions such as Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 5464-92-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,6 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5464-92:
(6*5)+(5*4)+(4*6)+(3*4)+(2*9)+(1*2)=106
106 % 10 = 6
So 5464-92-6 is a valid CAS Registry Number.
InChI:InChI=1/C15H15N.ClH/c1-2-7-13(8-3-1)15-14-9-5-4-6-12(14)10-11-16-15;/h1-9,15-16H,10-11H2;1H
5464-92-6Relevant academic research and scientific papers
SELECTIVE REDUCTION of 2-CARBAMOYL-1-PHENYL-1,4-DIHYDROISOQUINOLIN-3(2H)-ONES
Zara-Kaczian, Erzsebet,Deak, Gyula,Toth, Gabor
, p. 2533 - 2555 (2007/10/02)
Treatment of 2-carbamoyl-1-phenyl-1,4-dihydroisoquinolin-3(2H)-ones (1) with lithium aluminium hydride or diborane resulted always in the reduction of the ring carbonyl group and, depending on the nature of the reducing agent and the structure of the starting compound 1,2,3,4-tetrahydro- (2), 1,2-dihydroisoquinoline derivatives (3) or 1,2,3,4-tetrahydroisoquinolin-3-ols (5) were obtained.
